ANNUAL PHARMA PRICING, REIMBURSEMENT & MARKET ACCESS 2026

Annual Pharma Pricing, Reimbursement & Market Access 2026: Shaping the Future of Commercialization

Scheduled for October 6-8, 2026, in Philadelphia, PA, the Annual Pharma Pricing, Reimbursement & Market Access conference remains the premier global gathering for professionals navigating the complex, high-stakes landscape of bringing innovative therapies to patients and achieving sustainable market success. This event is an essential strategic forum for pricing strategists, market access leaders, HEOR experts, reimbursement specialists, government affairs professionals, and payer relations executives.

Core Focus Areas & Content Highlights:

1. Navigating Evolving Pricing & Reimbursement Landscapes:
Global Pricing Strategies: Adapting to divergent pricing pressures, inflationary trends, and value-based pricing (VBP) models across major markets (US, EU, Japan, emerging economies).
US Market Dynamics: Deep dives into the impact of the Inflation Reduction Act (IRA), Medicare price negotiation, Part D reforms, Medicaid coverage, and state-level initiatives. Strategies for managing rebates and navigating PBM negotiations.
EU & HTA Challenges: Understanding evolving Health Technology Assessment (HTA) processes (e.g., EMA/HTA collaboration), national reimbursement variations, and the push for greater harmonization and value demonstration.
Emerging Market Access: Strategies for addressing affordability constraints, tiered pricing, local manufacturing, and navigating diverse healthcare systems in high-growth regions.

2. Demonstrating Value & Securing Reimbursement:
HEOR & Real-World Evidence (RWE): Utilizing robust Health Economics and Outcomes Research (HEOR) data and RWE to build compelling value propositions, support pricing, and secure formulary placement. Integrating patient-reported outcomes (PROs) and real-world data (RWD).
Value-Based Agreements (VBAs): Designing, implementing, and negotiating innovative payment models (e.g., outcomes-based, risk-sharing, subscription models) that align payer and manufacturer interests and manage uncertainty. Overcoming operational and data-sharing hurdles.
Payer Engagement & Negotiation Tactics: Building effective payer relationships, understanding payer decision-making processes, mastering negotiation strategies for coverage and reimbursement, and communicating complex value narratives effectively.

3. Market Access Execution & Commercialization:
Launch Excellence: Integrating pricing, access, and market access planning early in the development lifecycle to ensure smooth commercialization. Addressing launch challenges in competitive and value-sensitive environments.
Lifecycle Management: Strategies for maintaining and extending market access throughout a product's lifecycle, including managing generic/biosimilar competition and maximizing value through new indications or formulations.
Digital Health & Data Utilization: Leveraging digital tools for market access planning, payer engagement, patient support programs, and generating real-world insights to inform strategy.
Cross-Functional Alignment: Ensuring seamless collaboration between R&D, Market Access, Commercial, Medical Affairs, and Government Affairs to drive unified value demonstration and market success.

Why Attend?

This conference provides unparalleled opportunities to:
Gain Actionable Insights: Learn from leading experts, case studies, and data-driven analyses on the latest trends, challenges, and successful strategies.
Network Strategically: Connect with a diverse audience of peers, thought leaders, payers, and key stakeholders shaping the future of market access.
Future-Proof Your Strategy: Understand emerging disruptors (AI, advanced RWE, novel payment models) and develop proactive strategies to navigate uncertainty and secure sustainable reimbursement.
Benchmark Performance: Compare your organization's approaches against industry best practices and innovative models.

The 2026 event promises to be a critical hub for equipping pharma professionals with the knowledge, connections, and strategies to overcome current hurdles and thrive in an increasingly complex and value-driven global healthcare environment.